Thymic Development of β Cell Specific Regulatory T Cells in Neonatal NOD mice

This abstract has open access
Abstract Summary

Neonatal period is a critical window when central tolerance is established in an Autoimmune Regulator (Aire). However, not all self-antigens are expressed downstream of Aire and tolerance to some tissue restricted antigens might rely in part on peripheral dendritic cells (DCs). The relative contribution of thymically and peripherally derived antigens in the generation of neonatal β cell antigen specific CD4+ regulatory T cells (Tregs) is not well understood. We have recently shown ectopic expression of Insulin B9-23 and the insulin mimetope R22E within antigen presenting cells early in thymocyte development can protect mice from developing Type 1 Diabetes (T1D) through central tolerance mechanisms. However, it remains to be determined whether peripherally derived neo-antigens such as post-translationally modified (PTM) peptides, may also be transported to the thymus to impact thymocyte development. Pathogenic T cells that are specific for neo-antigens uniquely expressed in the pancreas may escape thymic selection. Therefore, we examined the role of a known PTM peptide, the hybrid insulin/chromogranin A (2.5HIP) peptide, on neonatal development of β cell specific T cells and Tregs. We found that adoptively transferred DCs pulsed with ChgA peptides into neonatal and adult BDC2.5 TCR Tg and WT NOD mice readily migrate to the thymus and impact the development of ChgA specific T cells. Additionally, we found targeting thymic Langerin+ dendritic cells with anti-Langerin linked to ChgA peptides also altered T cell development. In both experimental approaches, we found a robust increase in the ratio and number of ChgA specific Tregs in the presence of 2.5HIP PTM while also observing an increase in negative selection. Co-administration of exogenous antibody/IL-2 complexes greatly enhanced the frequency and number of thymic Foxp3+ Tregs. Together our data suggests neonatal exposure to PTM peptides can efficiently drive thymic development of β cell specific Tregs and may alter T1D pathogenesis.

Submission ID :
IDS3084
Submission Type
Abstract Topics

Associated Sessions

Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
Baylor College of Medicine
Bayor College of Medicine
Baylor College of Medicine

Abstracts With Same Type

Submission ID
Submission Title
Submission Topic
Submission Type
Primary Author
IDS81249
Poster Session C
Poster and flash poster
Dr Burcak Yesildag
IDS64147
Poster Session B
Poster and flash poster
Professor Leonard Harrison
IDS29151
Poster Session B
Poster and flash poster
Mr Laurits Holm
IDS83241
Poster Session C
Poster and flash poster
Dr Lenka Petruželková
IDS65212
Poster Session C
Poster and flash poster
Professor Mark Mamula
7 visits

KEY DATES

Event dates:
Thursday 25 October - Monday 29 October 2018

Abstract submission deadline:
Monday 14 May 2018

Abstract notification:
July 2018

Early registration deadline:
Monday 3 September 2018

Registration deadline:
Monday 15 October 2018

Contact
British Society for Immunology
+44 (0)20 3019 5901
congress@immunology.org